Mechanism of Action: Neprilysin Inhibitors
✉ Email this page to a colleague
Drugs with Mechanism of Action: Neprilysin Inhibitors
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alembic | SACUBITRIL AND VALSARTAN | sacubitril; valsartan | TABLET;ORAL | 213682-002 | May 28, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Torrent | SACUBITRIL AND VALSARTAN | sacubitril; valsartan | TABLET;ORAL | 213604-001 | Aug 22, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Alembic | SACUBITRIL AND VALSARTAN | sacubitril; valsartan | TABLET;ORAL | 213682-003 | May 28, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Torrent | SACUBITRIL AND VALSARTAN | sacubitril; valsartan | TABLET;ORAL | 213604-002 | Aug 22, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |